Geode Capital Management LLC Has $111.30 Million Stake in Waystar Holding Corp. $WAY

Geode Capital Management LLC boosted its position in shares of Waystar Holding Corp. (NASDAQ:WAY) by 7.1% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 3,398,053 shares of the company’s stock after purchasing an additional 224,908 shares during the period. Geode Capital Management LLC’s holdings in Waystar were worth $111,300,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of WAY. ANTIPODES PARTNERS Ltd boosted its stake in shares of Waystar by 120.1% in the 3rd quarter. ANTIPODES PARTNERS Ltd now owns 823 shares of the company’s stock valued at $31,000 after purchasing an additional 449 shares in the last quarter. Danske Bank A S acquired a new stake in shares of Waystar in the 4th quarter valued at approximately $52,000. EverSource Wealth Advisors LLC boosted its stake in shares of Waystar by 3,219.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,394 shares of the company’s stock valued at $57,000 after purchasing an additional 1,352 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Waystar by 613.4% in the 4th quarter. GAMMA Investing LLC now owns 1,762 shares of the company’s stock valued at $58,000 after purchasing an additional 1,515 shares in the last quarter. Finally, 1620 Investment Advisors Inc. acquired a new stake in shares of Waystar in the 4th quarter valued at approximately $77,000.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on WAY. Bank of America reduced their price target on shares of Waystar from $45.00 to $38.00 and set a “buy” rating on the stock in a research note on Friday, April 10th. Evercore set a $27.00 price target on shares of Waystar in a research note on Wednesday, February 18th. JPMorgan Chase & Co. reduced their price target on shares of Waystar from $40.00 to $38.00 and set an “overweight” rating on the stock in a research note on Thursday, April 30th. Morgan Stanley began coverage on shares of Waystar in a research note on Monday, March 30th. They issued an “equal weight” rating and a $28.00 price target on the stock. Finally, UBS Group reduced their price target on shares of Waystar from $41.00 to $37.00 and set a “buy” rating on the stock in a research note on Thursday, April 30th. Three investment analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $35.62.

Waystar Stock Down 1.1%

Shares of NASDAQ WAY opened at $20.00 on Friday. The company has a 50 day simple moving average of $21.99 and a 200 day simple moving average of $26.77. The firm has a market cap of $3.84 billion, a PE ratio of 29.85, a price-to-earnings-growth ratio of 0.80 and a beta of 0.10. Waystar Holding Corp. has a 1 year low of $17.89 and a 1 year high of $41.49. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.76 and a quick ratio of 1.76.

Waystar (NASDAQ:WAY) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.03. The business had revenue of $313.87 million during the quarter, compared to analyst estimates of $311.74 million. Waystar had a net margin of 10.90% and a return on equity of 6.99%. The firm’s quarterly revenue was up 22.4% on a year-over-year basis. During the same quarter last year, the business earned $0.32 EPS. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. On average, research analysts forecast that Waystar Holding Corp. will post 1.46 EPS for the current year.

About Waystar

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.